MAR 02, 2018 08:00 AM PST

Photoaffinity Probe Developed to Monitor Endogenous Cannabinoid Receptor 2 Expression and Ligand Engagement

WRITTEN BY: Mauri Brueggeman

Researchers in Europe and the United States collaborated to successfully develop a two-step photoaffinity probe to monitor endogenous G-protein coupled receptor (GPCR) cannabinoid receptor 2 (CB2R) expression and ligand engagement.  The group made up of scientists from institutions in The Netherlands, Switzerland, and the US examined the potential for CB2R use in the treatment of tissue injury and inflammatory diseases.  The CBR2 is found in immune system cells and is upregulated as a result of pathophysiological conditions.  They published their results in the Journal of the American Chemical Society in February 2018.

There are hundreds of described G-protein coupled receptors (GPCR) in the literature; GCPRs are a large and diverse family of transmembrane domain receptors that transmit extracellular signals to the cell.  Each contains seven segments that spans the width of the membrane.  GPCRs communicate through G-proteins to activate Ras or other signaling proteins to trigger intracellular signaling pathways. 

The authors write that the CB2R plays a critical role in cell migration and immunosuppression and shares 44% overall homology with the cannabinoid receptor 1 (CB1R) which is found primarily in the central nervous system.  CB2R activation alone may provide therapeutic benefits without side effects of CB1R activation so there has been work done to identify a CB2R agonist.  CB2R agonists like LEI101, HU308, and HU910, as reported by these authors, have demonstrated efficacy for chronic and inflammatory pain, neuro- and nephropathy, and other disorders in animal models.

The researchers faced challenges in determining the type of labeling that would work because of the variable surface expression level of GPCRs.  In addition, normal biochemical methods using antibodies against GPCR cannot be used because CB2R does not currently have specific antibodies against it.  Lastly, because GPCRs change conformation upon the ligand binding, labeling cannot inhibit those changes and signaling cascade process while also needing to avoid degradation.

The result is the development of a two-step photoaffinity-based protein profiling process which utilizes a small ligation handle, a fluorescent tag, and an element to cross-link the product (ligand with receptor) to assess endogenous expression using LEI121.  This is important to help drive research forward through demonstration of CB2R occupancy at the site of inflammation in patients.

Sources: NatureJournal of the American Chemical Society

About the Author
  • Mauri S. Brueggeman is a Medical Laboratory Scientist and Educator with a background in Cytogenetics and a Masters in Education from the University of Minnesota. She has worked in the clinical laboratory, taught at the University of Minnesota, and been in post secondary healthcare education administration. She is passionate about advances and leadership in science, medicine, and education.
You May Also Like
DEC 15, 2019
Cannabis Sciences
DEC 15, 2019
Cannabis Genetics 101
This is an introduction into cannabis genetics including chromosome number, genetic variation leading to expression differences, and genome size....
DEC 15, 2019
Health & Medicine
DEC 15, 2019
Gene Linked To Cannabis Abuse
Research shows that there may be a specific gene associated with a higher risk of cannabis abuse. The same gene is responsible for the so-called nicotine r...
DEC 15, 2019
Cannabis Sciences
DEC 15, 2019
Cannabidiol's Role in Psychiatry
How can health professionals in the clinical psychiatry field make sense of cannabis products boasting various health claims? One professor’s present...
DEC 15, 2019
Health & Medicine
DEC 15, 2019
Medical Marijuana Allowed in California K-12 Schools
Gavin Newson, the governor of California and the leading 2016 proponent of the recreational pot legalization initiative Proposition 64, signed a bill on We...
DEC 15, 2019
Cannabis Sciences
DEC 15, 2019
U.S.A. Triathlon Makes Landmark Sponsorship Deal with CBD Company
U.S.A. Triathlon has just made a sponsorship deal with a company selling CBD products. This is a first for national governing bodies. Athletes, who often a...
DEC 15, 2019
Cannabis Sciences
DEC 15, 2019
Zebrafish Development Thwarted by Blocked Cannabinoids
Cannabinoid receptors of the endocannabinoid system (ECS) are vital pieces of the puzzle for the ECS to function correctly; the ECS needs cannabinoid recep...
Loading Comments...